25 of the Best Hematologist Oncologists Near Me in Oakland, CA

Ashutosh Lal is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Lal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Elliott Vichinsky is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vichinsky is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Mark Walters is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Walters is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Hemoglobinopathy, Congenital Hemolytic Anemia, Sickle Cell Disease, Hemolytic Anemia, and Bone Marrow Transplant.

Sylvia Singer is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Singer is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Thalassemia, Beta Thalassemia, Hemoglobinopathy, Congenital Hemolytic Anemia, and Splenectomy.

Carolyn Hoppe is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Hoppe is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia.

James Feusner is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Feusner is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Acute Promyelocytic Leukemia, Hepatoblastoma, Acute Myeloid Leukemia (AML), and Leukemia.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Christopher Dvorak is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Dvorak is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Primary Immunodeficiency (PID), Bone Marrow Transplant, and Splenectomy.

Arun Rangaswami is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Rangaswami is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Hepatoblastoma, Fibrolamellar Carcinoma, Rhabdoid Tumor, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Angela Rivers is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Rivers is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Anemia.

Caroline Hastings is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Hastings is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Niemann-Pick Disease, Non-Langerhans-Cell Histiocytosis, Reticulohistiocytoma, and Histiocytosis.

Michael Bookman is an Oncologist and a Hematologist Oncology provider practicing medicine in San Francisco, California. Dr. Bookman is highly rated in 1 condition, according to our data. His clinical expertise encompasses Ovarian Cancer, Testicular Yolk Sac Tumor, Ovarian Carcinosarcoma, and Virilizing Ovarian Tumor. Dr. Bookman is currently accepting new patients.

Robert Weber is a Hematologist and an Oncologist practicing medicine in Daly City, California. Dr. Weber is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer. Dr. Weber is board certified in Internal Medicine (Sub: Medical Oncology), Internal Medicine (Sub: Hematology), and Internal Medicine. Dr. Weber is currently accepting new patients.

Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mycosis Fungoides, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.

Dr. Rebecca Olin is a hematologist who specializes in bone marrow transplantation in adults. Her expertise encompasses treating acute leukemia, myelodysplastic and myeloproliferative disorders (conditions in which the bone marrow makes too many white blood cells) and aplastic anemia (a condition in which the body doesn’t make enough new blood cells). In her research, Olin has a particular interest in studying how best to treat blood cancers in older patients, some of whom may require a bone marrow transplant. Olin earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania and was elected to the Alpha Omega Alpha Honor Medical Society. She completed a residency in internal medicine as well as a fellowship in hematology and oncology at the Hospital of the University of Pennsylvania, serving as chief fellow for one year. She also has a master's degree in clinical epidemiology, with a focus on medical decision making, from the University of Pennsylvania. Dr. Olin is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Olin is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Olin is currently accepting new patients.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Chung is currently accepting new patients.

Dr. James Rubenstein is a hematologist-oncologist, or a specialist in blood disorders. He has particular expertise in treating patients with neurologic complications from cancer, including patients with non-Hodgkin's lymphoma involving the brain (called central nervous system lymphoma). He also specializes in patients with cancer that has spread to the brain from other parts of the body. In his research, Rubenstein investigates immunologic tools to improve tumor response to chemotherapy and radiation treatment, and to minimize toxicity from treatment. He is also interested in developing tumor biomarkers to diagnose brain tumors. Rubenstein earned his medical degree at Weill Cornell Medicine and completed a residency in internal medicine at Stanford Medicine. He earned a doctorate in molecular and cellular neurosciences at the Rockefeller University. He completed a fellowship in hematology and oncology at UCSF, which included training in neuro-oncology. Rubenstein has won research awards from the Leukemia & Lymphoma Society and the National Cancer Institute. He is a member of the American Society of Hematology, American Society of Clinical Oncology and American Association for Cancer Research. Dr. Rubenstein is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primary Lymphoma of the Brain, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Vitrectomy. Dr. Rubenstein is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Rubenstein is currently accepting new patients.

Dr. Chia-Ching Wang, who goes by Jackie, is an oncologist who treats anal cancer. She also provides cancer screenings with high-resolution anoscopy (an examination using an instrument that can be inserted into the anal canal). Wang's work in research focuses on HIV oncology, particularly HPV-related cancers. (HIV-infected individuals may be at higher risk for developing HPV-related cancers due to their immunosuppression. She hopes to develop and implement prevention strategies, as well as test novel therapies that may improve outcomes for patients with these cancers.) She has also completed studies on lymphoma and Kaposi's sarcoma. She has special interests in superficially invasive squamous cell carcinoma of the anus and in post-treatment surveillance. Wang received her medical degree from the State University of New York at Stony Brook. She began a residency in obstetrics and gynecology at Women & Infants Hospital of Rhode Island, but after the first year, she decided to change her focus to HIV-related work. She subsequently completed a research fellowship at the Miriam Hospital, a teaching affiliate of the Warren Alpert Medical School of Brown University. She then completed a residency in internal medicine at Brown University. After working for a year as a hospitalist (a physician dedicated to patient care in the hospital setting), she came to UCSF for a fellowship in hematology and oncology. Wang is a member of the American Society of Hematology, American Society of Clinical Oncology and American Medical Association. Dr. Wang is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Small Cell Lung Cancer (SCLC), Familial Colorectal Cancer, and Lung Cancer. Dr. Wang is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Wang is currently accepting new patients.

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007. Dr. Wolf is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wolf is board certified in American Board Of Internal Medicine/Hematology, Hematology and American Board Of Internal Medicine, Internal Medicine. Dr. Wolf is currently accepting new patients.

Carla Golden is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Golden is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Hepatoblastoma, Langerhans Cell Histiocytosis, Reticulohistiocytoma, Histiocytosis, and Bone Marrow Aspiration.

Swati Andhavarapu is a Hematologist Oncology specialist and a Hematologist practicing medicine in San Leandro, California. Dr. Andhavarapu is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Andhavarapu is currently accepting new patients.

Kieuhoa Vo is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Vo is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Ganglioneuroblastoma, and Gliomatosis Cerebri.

Katherine Matthay is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Matthay is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Ganglioneuroblastoma, and Bone Marrow Transplant.

Madhav Vissa is a Hematologist and an Oncologist practicing medicine in Oakland, California. Dr. Vissa is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Thalassemia, Sickle Cell Disease, Beta Thalassemia, and Hemoglobinopathy.

Robert Goldsby is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Goldsby is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Osteosarcoma, Adult Soft Tissue Sarcoma, Ewing Sarcoma, Bone Tumor, and Bone Marrow Aspiration.